An early-stage biotechnology corporation that focuses on the development of advanced, synthetic polymers for targeted drug delivery. Intezyne has designed the proprietary IVECT™ drug delivery platform to specifically target diseased cells, thus improving the success of therapeutic treatment while also minimizing harmful side effects.